[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].

Debruyne, Frans; Boyle, Peter; Calais da Silva, Fernando; Gillenwater, Jay G; Hamdy, Freddie C; Perrin, Paul; Teillac, Pierre; Vela-Navarrete, Remigio; Raynaud, Jean-Pierre; Schulman, Claude

[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis]. / Evaluation du bénéfice clinique de Permixon et de la tamsulosine dans le traitement de l'hypertrophie bénigne de la prostate (HBP) sévère: analyse d'un sous-groupe de l'étude PERMAL.

Debruyne, Frans; Boyle, Peter; Calais da Silva, Fernando; Gillenwater, Jay G; Hamdy, Freddie C; Perrin, Paul; Teillac, Pierre; Vela-Navarrete, Remigio; Raynaud, Jean-Pierre; Schulman, Claude.

Affiliation

Debruyne F; Hôpital Universitaire Saint Radboud, Nijmegen, Pays-Bas. f.debruyne@uro.ucm.nl

Prog Urol ; 14(3): 326-31, 2004 Jun.

Article in Fr | MEDLINE | ID: mdl-15373174

Subject(s)

Adrenergic alpha-Antagonists/therapeutic use; Androgen Antagonists/therapeutic use; Plant Extracts/therapeutic use; Prostatic Hyperplasia/drug therapy; Sulfonamides/therapeutic use; Aged; Double-Blind Method; Humans; Male; Middle Aged; Serenoa; Severity of Illness Index; Tamsulosin

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Sulfonamides / Plant Extracts / Adrenergic alpha-Antagonists / Androgen Antagonists Type of study: Clinical_trials Limits: Aged / Humans / Male / Middle aged Language: Fr Journal: Prog Urol Journal subject: UROLOGIA Year: 2004 Type: Article Affiliation country: Netherlands

Search on Google

XML

PubMed Links